These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 15966227
1. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test. Huang WS, Lu SN, Wang JH, Lee CM, Tung HD, Chen TM, ChangChien CS. Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227 [Abstract] [Full Text] [Related]
2. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H. Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110 [Abstract] [Full Text] [Related]
3. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction]. Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M. Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351 [Abstract] [Full Text] [Related]
4. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR. J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [Abstract] [Full Text] [Related]
5. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P. Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693 [Abstract] [Full Text] [Related]
6. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G. J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [Abstract] [Full Text] [Related]
7. [Evaluation of the patients with low levels of anti-HCV positivity]. Zer Y, Karaoğlan I, Ciçek H, Karağoz ID, Sağlam M. Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390 [Abstract] [Full Text] [Related]
8. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). Myrmel H, Navaratnam V, Asjø B. J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611 [Abstract] [Full Text] [Related]
9. A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon. Njouom R, Tejiokem MC, Zanga MC, Pouillot R, Ayouba A, Pasquier C, Nerrienet E. J Virol Methods; 2006 May; 133(2):223-6. PubMed ID: 16360220 [Abstract] [Full Text] [Related]
10. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?]. Sayan M, Meriç M, Mutlu B, Celebi S, Willke A. Mikrobiyol Bul; 2006 May; 40(1-2):81-4. PubMed ID: 16775961 [Abstract] [Full Text] [Related]
11. [Efficacy of absorbance ratio of ELISA antibodies [corrected] for hepatitis C virus of 3th generation in the prediction of viremia evaluated by PCR]. Vázquez-Avila I, Vera-Peralta JM, Alvarez-Nemegyei J, Rodríguez-Carvajal O. Rev Gastroenterol Mex; 2007 May; 72(1):34-9. PubMed ID: 17685198 [Abstract] [Full Text] [Related]
12. [Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase]. Hmaïed F, Ben Mamou M, Arrouji Z, Slim A, Ben Redjeb S. Pathol Biol (Paris); 2007 Mar; 55(2):121-6. PubMed ID: 16631320 [Abstract] [Full Text] [Related]
13. Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies detectable by third-generation enzyme immunoassay. Hadlich E, Alvares-Da-Silva MR, Dal Molin RK, Zenker R, Goldani LZ. J Gastroenterol Hepatol; 2007 Sep; 22(9):1506-9. PubMed ID: 17716354 [Abstract] [Full Text] [Related]
14. Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection. Rao HY, Ren FR, Guan WL, Houde M, Du SC, Liu CL, Gong XY, Wei L. J Virol Methods; 2009 Dec; 162(1-2):203-7. PubMed ID: 19703491 [Abstract] [Full Text] [Related]
15. [Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection]. Payan C, Raimbert A, Fouchard-Hubert I, Kouyoumdjian S, Lunel-Fabiani F. Ann Biol Clin (Paris); 2003 Dec; 61(3):311-7. PubMed ID: 12805008 [Abstract] [Full Text] [Related]
16. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. León P, López JA, Elola C, Domingo CJ, Echevarria JM. Vox Sang; 1996 Dec; 70(4):213-6. PubMed ID: 9123926 [Abstract] [Full Text] [Related]
17. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China. Wu S, Liu Y, Cheng L, Yin B, Peng J, Sun Z. J Med Virol; 2011 Nov; 83(11):1930-7. PubMed ID: 21915868 [Abstract] [Full Text] [Related]
18. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Hussein MM, Mooij JM, Hegazy MS, Bamaga MS. Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902 [Abstract] [Full Text] [Related]
19. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]. Contreras AM, Ochoa-Jiménez RJ, Kershenobich D, Granados-García V, Conde-González CJ, Celis A, Pérez-Gómez HR, Ruelas-Hernández S, Romero-Flores P, Alcántar-Luna E, Sierra-García de Quevedo J, Ancona-Pisté O, Grupo de Desarrollo de la Guía. Rev Invest Clin; 2012 Mar; 64(6 Pt 2):641-78. PubMed ID: 23593783 [Abstract] [Full Text] [Related]
20. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients. Macedo de Oliveira A, White KL, Beecham BD, Leschinsky DP, Foley BP, Dockter J, Giachetti C, Safranek TJ. J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]